Your browser is no longer supported. Please, upgrade your browser.
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E30.41 EPS (ttm)6.79 Insider Own11.70% Shs Outstand908.04M Perf Week2.89%
Market Cap196.85B Forward P/E23.53 EPS next Y8.77 Insider Trans-0.58% Shs Float856.57M Perf Month-1.74%
Income6.19B PEG2.62 EPS next Q2.20 Inst Own83.40% Short Float0.77% Perf Quarter42.64%
Sales24.54B P/S8.02 EPS this Y36.90% Inst Trans6.92% Short Ratio1.53 Perf Half Y38.60%
Book/sh6.21 P/B33.25 EPS next Y4.98% ROA14.30% Target Price216.14 Perf Year63.70%
Cash/sh3.86 P/C53.47 EPS next 5Y11.60% ROE140.40% 52W Range117.06 - 218.00 Perf YTD22.29%
Dividend3.40 P/FCF81.19 EPS past 5Y24.60% ROI22.60% 52W High-5.29% Beta0.27
Dividend %1.65% Quick Ratio1.10 Sales past 5Y4.20% Gross Margin77.70% 52W Low76.38% ATR4.83
Employees35000 Current Ratio1.40 Sales Q/Q21.70% Oper. Margin24.70% RSI (14)60.69 Volatility2.25% 2.44%
OptionableYes Debt/Eq2.94 EPS Q/Q41.70% Profit Margin25.20% Rel Volume0.65 Prev Close204.89
ShortableYes LT Debt/Eq2.94 EarningsJan 29 BMO Payout43.40% Avg Volume4.29M Price206.47
Recom2.20 SMA201.67% SMA508.80% SMA20028.30% Volume2,795,194 Change0.77%
Jan-19-21Upgrade Mizuho Neutral → Buy $164 → $222
Dec-10-20Upgrade Wolfe Research Peer Perform → Outperform $147 → $183
Nov-10-20Resumed Bernstein Mkt Perform $150
Sep-29-20Initiated Berenberg Hold $144
Sep-03-20Upgrade Morgan Stanley Equal-Weight → Overweight $176
Jun-16-20Upgrade Guggenheim Neutral → Buy
Apr-21-20Downgrade UBS Buy → Neutral $157 → $158
Apr-09-20Downgrade Morgan Stanley Overweight → Equal-Weight $148
Feb-06-20Initiated Mizuho Neutral
Dec-18-19Upgrade Morgan Stanley Equal-Weight → Overweight $116 → $150
Oct-17-19Resumed BofA/Merrill Buy $133
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Feb-28-21 11:30AM  
Feb-26-21 05:50PM  
05:44PM  
12:35PM  
10:37AM  
09:25AM  
08:15AM  
07:48AM  
07:22AM  
07:11AM  
07:00AM  
Feb-25-21 06:45AM  
Feb-24-21 04:58PM  
03:00PM  
09:31AM  
Feb-23-21 05:18PM  
02:43AM  
Feb-21-21 07:21AM  
Feb-18-21 12:40PM  
10:18AM  
08:14AM  
07:17AM  
06:52AM  
06:30AM  
04:35AM  
Feb-17-21 09:29AM  
08:58AM  
06:45AM  
06:30AM  
Feb-12-21 02:33PM  
10:00AM  
09:35AM  
08:56AM  
Feb-11-21 04:30PM  
Feb-10-21 04:15PM  
01:50PM  
01:32PM  
10:33AM  
08:05AM  
07:56AM  
07:34AM  
04:13AM  
02:45AM  
Feb-09-21 08:24PM  
07:29PM  
11:40AM  
11:19AM  
07:33AM  
07:23AM  
07:21AM  
07:18AM  
07:00AM  
03:49AM  
Feb-08-21 07:00PM  
12:13PM  
Feb-07-21 01:44PM  
01:27PM  
07:00AM  
Feb-06-21 05:36PM  
02:41AM  
Feb-05-21 01:45PM  
12:40PM  
11:19AM  
11:05AM  
Feb-04-21 04:30PM  
10:21AM  
Feb-03-21 05:16PM  
01:00PM  
10:11AM  
08:56AM  
06:44AM  
Feb-02-21 07:55AM  
12:03AM  
Feb-01-21 07:30AM  
Jan-29-21 06:30PM  
05:26PM  
04:24PM  
12:02PM  
11:16AM  
10:43AM  
10:29AM  
10:22AM  
09:19AM  
09:11AM  
09:01AM  
08:32AM  
07:03AM  
06:37AM  
06:31AM  
06:20AM  
03:56AM  
01:48AM  
01:38AM  
Jan-28-21 10:57AM  
10:28AM  
10:10AM  
10:05AM  
08:49AM  
08:00AM  
06:34AM  
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products worldwide. It offers Baqsimi for severe hypoglycemia; Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500, and Lyumjev for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company also provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+ and HER2- metastatic breast cancer. In addition, it offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Further, the company Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; Reyvow for migraine; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Additionally, it Bamlanivimab and etesevimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; AbCellera Biologics Inc.; and Junshi Biosciences. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.005,445027,425Feb 03 06:29 PM
Shah Aarti S.SVP & CIDOFeb 01Option Exercise0.006,282023,369Feb 03 07:02 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0075,3870343,639Feb 03 06:57 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0016,754035,400Feb 03 07:26 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Feb 01Option Exercise0.006,282010,592Feb 03 06:51 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.0012,146056,919Feb 03 06:43 PM
Norton JohnaSenior VP, Global QualityFeb 01Option Exercise0.003,435020,953Feb 03 06:38 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0015,0780115,289Feb 03 06:33 PM
Smiley Joshua LSVP and CFOFeb 01Option Exercise0.0019,266060,702Feb 03 08:22 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale190.80215,00041,022,862110,487,343Jan 19 01:04 PM
LILLY ENDOWMENT INC10% OwnerJan 13Sale185.97210,00039,053,064110,702,343Jan 14 11:23 AM
LILLY ENDOWMENT INC10% OwnerJan 11Sale185.49220,00040,807,754110,912,343Jan 12 11:27 AM
Smiley Joshua LSVP and CFOOct 01Option Exercise0.007,947044,918Oct 05 12:19 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMSep 08Sale151.015,000755,05023,580Sep 10 04:25 PM
Mason Michael BSr. VP & Pres., Lilly DiabetesSep 01Option Exercise0.006,244021,279Sep 02 05:04 PM
Fry Stephen FSVP, HR & DiversityAug 17Sale150.647,2041,085,211100,211Aug 18 03:31 PM
LILLY ENDOWMENT INC10% OwnerJul 09Sale169.6912,9612,199,392111,132,343Jul 10 02:16 PM
Zulueta Alfonso GSVP & President, Lilly Int'lJul 09Sale170.0011,0001,870,00018,646Jul 13 01:43 PM
LILLY ENDOWMENT INC10% OwnerJul 07Sale167.29210,00035,131,799111,145,304Jul 08 12:49 PM
LILLY ENDOWMENT INC10% OwnerJul 06Sale166.99205,00034,232,086111,379,612Jul 07 02:27 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,46805,424Jul 06 04:50 PM
LILLY ENDOWMENT INC10% OwnerJun 30Sale163.20166,83227,227,760111,560,304Jul 01 11:17 AM
LILLY ENDOWMENT INC10% OwnerJun 29Sale163.3911,4311,867,760111,727,136Jun 30 03:12 PM
LILLY ENDOWMENT INC10% OwnerJun 26Sale163.0131,7375,173,404111,738,567Jul 01 09:55 AM
LILLY ENDOWMENT INC10% OwnerJun 26Sale163.0131,7375,173,404111,738,567Jun 30 02:48 PM
LILLY ENDOWMENT INC10% OwnerJun 18Sale161.5453,7708,686,046111,770,304Jun 19 02:21 PM
LILLY ENDOWMENT INC10% OwnerJun 17Sale161.38161,23026,019,469111,824,074Jun 18 05:16 PM
Zulueta Alfonso GSVP & President, Lilly Int'lJun 16Sale162.9417,0002,770,00029,646Jun 18 09:36 AM
LILLY ENDOWMENT INC10% OwnerJun 16Sale162.92212,33734,593,145111,985,304Jun 17 03:13 PM
Zulueta Alfonso GSVP & President, Lilly Int'lJun 05Sale150.0010,0001,500,00046,646Jun 09 04:52 PM
LILLY ENDOWMENT INC10% OwnerApr 27Sale163.6012,6632,071,715112,197,641Apr 28 12:21 PM
LILLY ENDOWMENT INC10% OwnerApr 24Sale162.47220,00035,743,218112,210,304Apr 27 02:36 PM
LILLY ENDOWMENT INC10% OwnerApr 23Sale160.12230,00036,826,587112,430,304Apr 27 10:39 AM
Shah Aarti S.SVP & CIOApr 14Sale150.002,000300,00019,087Apr 16 11:23 AM
LILLY ENDOWMENT INC10% OwnerApr 09Sale145.42230,00033,445,542112,660,304Apr 13 02:43 PM
LILLY ENDOWMENT INC10% OwnerApr 07Sale143.20172,31524,676,281112,890,304Apr 08 12:49 PM
LILLY ENDOWMENT INC10% OwnerApr 06Sale142.7315,9622,278,322113,062,619Apr 07 11:40 AM
LILLY ENDOWMENT INC10% OwnerApr 03Sale143.1926,7233,826,493113,078,581Apr 06 02:42 PM
LILLY ENDOWMENT INC10% OwnerApr 02Sale140.78166,03823,374,654113,105,304Apr 03 12:42 PM
LILLY ENDOWMENT INC10% OwnerMar 31Sale140.0738,9625,457,474113,271,342Apr 01 01:47 PM
LILLY ENDOWMENT INC10% OwnerMar 30Sale139.11210,00029,213,559113,310,304Mar 31 04:03 PM
Fry Stephen FSVP, HR & DiversityMar 30Sale134.3014,6571,968,434107,415Mar 31 11:50 AM
Norton JohnaSenior VP, Global QualityMar 16Sale131.004,727619,23717,674Mar 18 10:44 AM
O'Neill MylesSVP & Pres., Mfg. OperationsMar 04Sale140.1525,0003,503,7508,469Mar 06 10:46 AM
Zakrowski Donald AChief Accounting OfficerMar 02Sale128.003,700473,6004,740Mar 03 03:27 PM